Free Trial

Insider Selling: Xometry (NASDAQ:XMTR) Director Sells 1,000 Shares of Stock

Xometry logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Emily Rollins, a Xometry director, sold 1,000 shares on April 1 at an average price of $42.02 under a pre-arranged Rule 10b5-1 plan, generating $42,020 and reducing her holdings to 15,136 shares (a 6.20% decrease, ~$636,015).
  • Xometry shares traded near $42.35 with a one-year range of $18.59–$73.87 and a market cap of ~$2.19B; the company reported quarterly revenue of $192.4M (up 29.5% year-over-year) and an EPS beat, but remains unprofitable with negative margins and a projected -0.66 EPS for the fiscal year.
  • Institutional investors own about 97.31% of the stock, while analyst coverage is mixed (five Buy, five Hold, one Sell), giving an average rating of "Hold" and an average price target of $62.00.
  • MarketBeat previews top five stocks to own in May.

Xometry, Inc. (NASDAQ:XMTR - Get Free Report) Director Emily Rollins sold 1,000 shares of the company's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $42.02, for a total transaction of $42,020.00. Following the completion of the sale, the director owned 15,136 shares of the company's stock, valued at $636,014.72. This represents a 6.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Xometry Stock Performance

NASDAQ XMTR remained flat at $42.35 during trading on Friday. The company's stock had a trading volume of 805,647 shares, compared to its average volume of 891,517. Xometry, Inc. has a one year low of $18.59 and a one year high of $73.87. The business's 50 day simple moving average is $49.73 and its two-hundred day simple moving average is $54.72. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.76 and a quick ratio of 3.72. The company has a market cap of $2.19 billion, a P/E ratio of -34.71 and a beta of 0.88.

Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings results on Tuesday, February 24th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.04. The company had revenue of $192.40 million during the quarter, compared to the consensus estimate of $183.37 million. Xometry had a negative return on equity of 5.49% and a negative net margin of 8.99%.The firm's revenue was up 29.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.06 EPS. Equities research analysts predict that Xometry, Inc. will post -0.66 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Kemnay Advisory Services Inc. acquired a new stake in shares of Xometry in the fourth quarter worth $28,000. Quantbot Technologies LP bought a new stake in Xometry in the 3rd quarter valued at $30,000. Advisors Asset Management Inc. boosted its holdings in Xometry by 68.3% in the 2nd quarter. Advisors Asset Management Inc. now owns 1,015 shares of the company's stock valued at $34,000 after purchasing an additional 412 shares during the period. Westend Capital Management LLC acquired a new stake in Xometry in the 3rd quarter worth $41,000. Finally, GAMMA Investing LLC grew its position in Xometry by 26.5% in the 4th quarter. GAMMA Investing LLC now owns 773 shares of the company's stock worth $46,000 after purchasing an additional 162 shares during the last quarter. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently weighed in on XMTR shares. William Blair restated an "outperform" rating on shares of Xometry in a research note on Tuesday, February 24th. Zacks Research upgraded shares of Xometry from a "strong sell" rating to a "hold" rating in a report on Monday, March 2nd. Weiss Ratings reissued a "sell (e+)" rating on shares of Xometry in a research report on Wednesday, January 21st. UBS Group upped their price target on shares of Xometry from $54.00 to $55.00 and gave the company a "neutral" rating in a report on Wednesday, February 25th. Finally, Royal Bank Of Canada lowered their price target on Xometry from $64.00 to $55.00 and set a "sector perform" rating on the stock in a research report on Wednesday, February 25th. Five equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $62.00.

Get Our Latest Analysis on XMTR

About Xometry

(Get Free Report)

Xometry, Inc NASDAQ: XMTR operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.

Featured Stories

Insider Buying and Selling by Quarter for Xometry (NASDAQ:XMTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines